| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $226K | +0.0% |
| R&D Expense | $11.4M | +56.3% |
| SG&A Expense | $8.4M | -10.4% |
| Operating Income | -$19.6M | -19.0% |
| Pre-tax Income | -$19.0M | -17.3% |
| Net Income | -$19.0M | -17.3% |
| EPS (Basic) | -$0.91 | +5.2% |
| EPS (Diluted) | -$0.91 | +5.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.5M | — |
| Accounts Receivable | $29K | +3.6% |
| Current Assets | $39.3M | -29.0% |
| Total Assets | $39.4M | -29.0% |
| Current Liabilities | $8.0M | +31.6% |
| Total Liabilities | $11.1M | +18.2% |
| Stockholders' Equity | $28.3M | -38.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.3M | +16.4% |
| Financing Cash Flow | $55.6M | +0.0% |